As the number of surgeries performed annually continues to climb, demand for reliable diagnostics to manage hospital-acquired infections has increased. The market is forecasted to rise from USD 43.1 billion in 2025 to USD 117.9 billion by 2035, with advanced molecular diagnostics driving adoption.